Pre-clinical services from a top preclinical CRO in Kiev, UA.
Our company is an independent CRO based in the USA that conducts pre-clinical drug testing in top-notch, GLP certified research facilities in Eastern Europe. Our testing sites are supported by the UNAMS and Ministry of Health and provide support for commercial development of new medicine discoveries as part of their core purpose. Our company was created to provide the top-notch, inexpensive services of these laboratories to emerging bio-technology companies in the United States and EU, thereby offering an attractive option for advancing development programs quickly and at much lower cost than other commercial Contract Research Organizations. We offer a broad range of pre-clinical toxicology including drug safety, acute and chronic toxicity, pharma screening, bio-availability , bioequivalence, and complete in vivo and in vitro screening for anti-cancer activity.
Our preclinical Contract Research Organization is able to price preclinical trials far below other Contract Research Organizations since we have a very low overhead in the United States and perform all studies in Kiev where labor and lab costs are much lower. Our team in the USA is comprised of only of the organization principals who work directly with customers; we don’t have any marketing expenses other than our website, and no main offices, administrative staff or other overhead to inflate costs. We have much lower trials conduct costs in Kiev, UA due to much lower workers rates and are happy to offer our most attractive rates for long-term and more intricate preclinical trials where labor is the greatest part of the overall price. Because we utilize the same reliable international providers for lab animals, reagents and laboratory supplies as other CROs, we have no cost advantage on these materials and so less overall cost advantage for very short-term preclinical tests. But, regardless of your trial protocol and duration, our goal is to give our clients the greatest possible value for their investment.